Ulcerative colitis drug study halted: new treatment vs. entyvio
Disease control
Terminated
This study tested whether a new drug called AVT16 works as well as the approved drug Entyvio for people with moderate to severe ulcerative colitis. The study planned to include 301 adults aged 18 to 80. However, the study was terminated early, so results may not be complete.
Phase: PHASE3 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated May 15, 2026 11:57 UTC